Qatar Pavilion

Health care is a cornerstone of a strong, active, and healthy society making a review of quality standards, calling for technological effectiveness and accessibility of medical care. HealthTech & MedTech innovations are focused on telemedicine, biotechnology, artificial intelligence, and big data tailored for digital health. And last year proved to be indicative of the growth in demand for virtual health care and innovative approach in the face of a pandemic. How has COVID-19 changed healthcare? How can we ensure sufficient funding for the growing demand for innovation in healthcare? What reforms are needed to further mobilize cutting-edge health models? Entrepreneurship and startup culture in the healthcare industry - ways of commercializing.

Moderator
Nick Bradshaw, Director of Partnerships and Outreach, World Innovation Summit for Health (WISH)

Panellists
Sultana Afdhal, Chief Executive Officer, World Health Innovation Summit (WISH)
Kirill Kaem, Senior Vice-President for Innovations, Skolkovo Foundation
Yury Krestinskiy, Vice President - Head of Healthcare Industry, Sberbank; Chairman of the Expert Council, Institute for Public Health Development
Denis Kuleshov, Innovator and Chief Executive Officer, Sensor-Tech
Mahmoud El Achi, Head of Innovation at the World Innovation Summit for Health (WISH)

Kirill Kaem

Senior Vice-President for Innovations, Skolkovo Foundation

Kirill Kaem, whose family have been doctors for no fewer than seven generations, graduated from the Kirov State Medical Academy in Nizhny Novgorod in 1992. Five years later he graduated with distinction from the economics department at the Lobachevsky State University, after successfully completing his studies in Russia and the USA on an MBA program run jointly with Taylor University. He has over 20 years' experience in senior management roles, including 15 years as a CEO at the corporation's various international branches. He specializes in launching start-ups in new regions and countries, and new business areas at major firms. From 1992 to 1994 he owned his own business, distributing medical equipment and pharmaceuticals. In 1995 Kirill Kaem set up a network of regional outlets for the Swedish company Oriflame in the Volga Region, which helped it become one of the region's biggest tax-payers. In the year 2000 he began working in Germany, in the central office of the company Varta. After Varta's merger with the American group Spectrum Brands, he spent eight years in overall charge of the company's operations in Russia. In 2008 he relaunched the German and American holding JAFRA International in Russia, improving profit margins by 40%. In 2009 he took control of the Russian holding Hygiene Kinetics, the biggest manufacturer in the market for domestic paper and cellulose products. Within two years the company's sales growth was several times higher than average growth in the sector, thanks to the introduction of new technologies. From 2011 to 2013 he headed up a new area of business at 'Alpha Group' - the biggest federal chain of clinics, 'Alpha Health Centre', where in the space of a year he managed to double revenue, whilst the chain itself saw profits rise by over a third. From 2013 onwards he has been a member of the Board of Directors and a co-founder of the international medical centre 'Medcluster', set up at the initiative of Sberbank in partnership with Strategy Group Partners, with Johns Hopkins Medicine International as a potential partner. From 2013-2017 he was director of the Skolkovo Foundation’s biomed cluster.

Yury Krestinskiy

Vice President - Head of Healthcare Industry, Sberbank; Chairman of the Expert Council, Institute for Public Health Development

Since 2016: head of research centre for economics and management in healthcare at the Skolkovo management school in Moscow. The centre's primary objective is to conduct research on effective management, economics and informational support for Russia's healthcare system and to create and implement educational programmes promoting development of professional healthcare managers. Since 2007: Director of Institute of Public Healthcare Development. Key recent project: Moscow Medical Cluster. 1993 foundation of the Bionika group, CEO. 2007: headed the Department of Pharmaceutical Activities, Regional and Information Policy at the Ministry of Health and Social Development of the Russian Federation. Apart from the activities covered by the name of the department, supervised development of high-tech medical care in the Russian Federation and engaged foreign specialists. Civil engagement: Since 2003: member of the coordinating council of the Russian Association of Pharmacy Chains. Since 1999: co-chairman of the coordinating council of the Russian Association for Pharmaceutical Marketing. 1995–2002: Association of Commercial Pharmaceutical Organizations PharmAsk, Deputy CEO. Works with the Institute of Public Healthcare Development and various professional committees under different government agencies. Has a versatile investment portfolio including projects in film, fitness (he is also an instructor in qigong and tai chi), fresh water supply, R&D of new medical products, venture projects, etc. Promotes young entrepreneurs. Has five children.